Discovery Clinical Research Inc is categorized under Medical Labs in Encinitas, CA and active since 2008.
Discovery Clinical Research Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Piyush Kumar at the company’s single location by writing to 700 Garden View Court # 102, Encinitas, California CA 92024 or by phoning (760) 274-2704. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Discovery Clinical Research Inc |
| Contact Person: | Piyush Kumar |
| Address: | 700 Garden View Court # 102, Encinitas, California 92024 |
| Phone Number: | (760) 274-2704 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Discovery Clinical Research Inc was started in 2008 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Piyush Kumar for inquiries that concern Discovery Clinical Research Inc by calling the company number (760) 274-2704, as your correspondence is most welcome. Additionally, the physical location of the single location of Discovery Clinical Research Inc can be found at the coordinates 33.060431,-117.260782 as well as the street address 700 Garden View Court # 102 in Encinitas, California 92024.
For its online presence, you may visit Discovery Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.